Search earnings tickers

ALNY

2024Q2BMO

Alnylam Pharmaceuticals Inc primary · HEALTHCARE · BIOTECHNOLOGY

Report 2024-08-01 · Fiscal end 2024-06-30 · Features as of 2024-07-31

← Earnings history

Street

Consensus EPS-0.69

Consensus rev—

EPS high—

EPS low—

Dispersion—

Analysts—

EPS rev net 7d—

EPS rev net 30d—

Consensus Δ 7d—

Consensus Δ 30d—

Options

Implied move2.3%

IV front—

P/C full—

P/C front—

Features as of2024-07-31

Run-up

Close—

Ret 5d+0.4%

Ret 10d-1.1%

Ret 20d-4.1%

Ret 30d+51.0%

Print

Actual EPS

0.56Beat

Estimated EPS-0.69

Actual revenue

659.8M

Surprise %+181.2%

Beat / missBeat

Beat streak 42

Beat streak 82

Reaction

1-day stock reaction+7.4%

Implied vs actual

Implied 2.3%Actual 5.3%

Gap reaction+5.3%

Day result+13.1%

Next-day upYes

Realized / IV2.27×

Post tape

Post 5d+0.7%

Post 10d-2.2%

Post volume2.4M

Vol ×10d3.62×

Vol ×20d3.01×

Post range10.3%